Loading…
Live research highlights, drug-label updates and device clearances — pulled from PubMed and the FDA, refreshed hourly. Every item links to its original source.
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial
Lancet · 2025-11-20
Comparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen): a randomised, non-inferiority, three-arm, phase 3 trial
Lancet · 2025-11-20
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
Lancet · 2025-11-20
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
Lancet · 2025-11-12
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
Lancet · 2025-11-06
A multi-faceted hospital-based intervention for intrapartum care in sub-Saharan Africa: a stepped-wedge cluster-randomized trial.
Nat Med · 2026-08-26
Recombinant shingles vaccination and the risk of cardiovascular events.
Nat Med · 2026-08-26
Predictive Utility of Coronary Artery Calcium Score Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations.
JAMA · 2026-08-26
Educational only — not medical advice. Sourced from public PubMed & openFDA data; always consult the original publication or label.
Live coaching and subject-matter experts for MBBS, BDS, BAMS, NEET-PG, Pre-Med & MD. Book a session, clear your doubts, and learn the smart way.